Back Hepatitis B

Hepatitis B

EASL 2014: International Liver Congress Starts this Week in London

The European Association for the Study of the Liver's International Liver Congress (EASL 2014) takes place April 9-13 at the ExCel Centre in London. The annual conference is one of the key annual scientific meetings covering viral hepatitis and its complications. Also on Thursday, the World Health Organization (WHO) will release new global guidelines for hepatitis C.

alt

Read more:

U.S. Government Releases Updated Viral Hepatitis Action Plan

On April 3 the federal government released its latest 3-year update to the Action Plan for the Prevention, Care and Treatment of Viral Hepatitis (initially launched in 2011), which provides a framework for strengthening the nation's response to hepatitis B and C.

alt

Read more:

Can Coffee Help Prevent Liver Fibrosis?

There is good evidence that coffee has a beneficial effect in people at risk for liver fibrosis and there are plausible biological mechanisms to explain why, according to an editorial in the January 27 advance online edition of Hepatology. However, the amount needed to see such an effect may be too high for many people to tolerate, they cautioned.

alt

Read more:

Increased Distance Reduces Likelihood of Liver Transplant

alt

Living and receiving health care further away from a transplant center was associated with lower chances of being wait-listed for or receiving a liver transplant, according to a study of U.S. veterans described in the March 26 edition of JAMA.

Read more:

Chronic Hepatitis B Treatment Guidelines

CHB Treatment Guideline Navigator

Mark Sulkowski from Johns Hopkins and Tram Tran from Cedars Sinai Medical Center help readers understand and make decisions using current guidelines for treatment of people with chronic hepatitis B. This continuing medical education (CME) activity is available for free to all, with credit available for physicians and nurses.

alt

Read more:

Updated Entecavir Label Expands Indication for Children with Hepatitis B

The U.S. Food and Drug Administration (FDA) last week approved new label information for entecavir (Baraclude), a nucleoside analog used to treat chronic hepatitis B virus (HBV) infection. The revised label expands the indication for pediatric use by children age 2 years and up.

alt

Read more:

Monitoring Inactive Hepatitis B Is Cost-effective but Must Increase to Improve Survival

Lifelong monitoring of people with inactive hepatitis B virus (HBV) infection may be cost-effective, according to a study in China published the December 19 advance online edition of Hepatology. Monitoring and treatment would have to be substantially expanded, however, to achieve significant reductions in liver cancer and hepatitis B-related mortality.

alt

Read more:

New Guidelines for Hepatitis B Screening

U.S. Preventive Services Task Force this week released updated guidelines for hepatitis B virus (HBV) screening for adults. The draft recommendations call for screening of high-risk individuals including people with HIV, gay men, people who inject drugs, and people from parts of the world where hepatitis B is common.

alt

Read more:

CDC Updates Guidance for Hepatitis B Vaccination of Health-care Providers

The U.S. Centers for Disease Control and Prevention (CDC) has published updated guidance for evaluating and ensuring protection against hepatitis B virus (HBV) for health-care workers, as well as post-exposure prophylaxis recommendations for those without adequate vaccine protection.

alt

Read more: